Petrovax Pharm is a Russian full-cycle biotechnological company with 25 years of successful market experience. The product portfolio includes its original pharmaceutical products, localized drugs and vaccines, localized medicinal products, as well as contract medicines and food supplements. The company has a research center and holds patents for new molecules and pharmaceutical manufacturing technologies in Russia and abroad. The company’s investment program provides the financing of advanced R&D projects. Petrovax’s modern manufacturing complex for substance and finished dosage forms production located in Moscow Region operates in full compliance with the EAEU and EU GMP standards. The production capacity provides for manufacturing more than 160 million doses of immunobiological products per year. For ten years, the company has successfully confirmed compliance with the GMP EU certificate (Slovakia), which was first obtained in 2012. Petrovax is one of the largest Russian exporters of influenza vaccines and original pharmaceutical products, which are presented in 10 countries, including the EAEU, Middle East and EU countries. Petrovax's is the partner of international Big Pharma companies: Pfizer, Abbott, ISU ABXIS, Adimmune, Hengrui. The company's investment strategy is aimed at investigation, production development and import substitution of medicines and vaccines used in the treatment of socially significant conditions, such as oncological, autoimmune, infectious, and orphan diseases.
View Top Employees from Petrovax PharmWebsite | http://www.petrovax.com |
Revenue | $166.9 million |
Employees | 85 (70 on RocketReach) |
Founded | 1996 |
Address | 12 Presnenskaya Embankment Federation Tower East Fl 38, Moscow City, Moscow 123112, RU |
Phone | +7 495 730-75-45 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing, Drug Discovery |
SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Petrovax Pharm employee's phone or email?
The Petrovax Pharm annual revenue was $166.9 million in 2024.
Mikhail Tsyferov is the President of Petrovax Pharm.
70 people are employed at Petrovax Pharm.
Petrovax Pharm is based in Moscow City, Moscow.
The NAICS codes for Petrovax Pharm are [32, 3254, 325, 32541].
The SIC codes for Petrovax Pharm are [283, 2834, 28].